Hansjörg Wyss
About Hansjörg Wyss
Hansjörg Wyss is a Swiss entrepreneur and philanthropist renowned for his significant contributions to the biotechnology and healthcare sectors. He founded Synthes, a medical device manufacturer, and served as its CEO until its acquisition by Johnson & Johnson in 2012. This sale marked a pivotal moment in his career, leading him to focus on philanthropic endeavors through the Wyss Foundation, which supports various initiatives in conservation, education, and healthcare. The Wyss Foundation, established in 1998, is a private, charitable organization dedicated to supporting innovative solutions that improve lives and empower communities. The foundation has been instrumental in funding conservation efforts, including the Wyss Campaign for Nature, which aims to conserve 30% of the Earth's land and oceans by 2030. Additionally, Wyss has made substantial contributions to the Wyss Institute for Biologically Inspired Engineering at Harvard University, advancing research in biomedical engineering. Wyss's investment strategy is characterized by a commitment to sectors that align with his philanthropic goals, particularly in healthcare, biotechnology, and conservation. His approach emphasizes supporting organizations and initiatives that drive innovation and address global challenges, reflecting his dedication to fostering positive change through strategic investments and charitable activities.
Investment Mandate
Investment Stages5
Geographical Focus
African markets1
Other stated markets19
Requirements
Alignment with philanthropic goals, Focus on innovation and global impact, Commitment to sustainability and conservation
Stated Portfolio3
As reported by the investor. We hold no profile for these companies, so they are printed as stated rather than linked.
Is this you?
Claim this investor profile to manage your firm's information.
Claim this profileReport an error